Second-line treatment with carboplatin f
✍
Riccardo Soffietti; Mauro Nobile; Roberta Rudà; Marzia Borgognone; Alessandra Co
📂
Article
📅
2004
🏛
John Wiley and Sons
🌐
English
⚖ 85 KB
## Abstract ## BACKGROUND The efficacy of second‐line chemotherapy for patients with recurrent or progressive oligodendroglial tumors is limited. In the current study, the authors investigated the use of carboplatin as a second‐line chemotherapeutic agent against these types of tumors. ## METHODS